期刊文献+

脂质体介导骨保护素基因转染大鼠骨髓基质干细胞及其表达

Expression of osteoprotegerin gene mediated with liposome in rat bone marrow stromal cells
暂未订购
导出
摘要 背景:基因修饰骨组织工程种子细胞,可提高对骨缺损的修复能力。目的:构建含有骨保护素的真核表达载体并检测转染骨髓基质干细胞后的表达。方法:取4周龄SD大鼠胫骨和股骨行骨髓基质干细胞的分离和培养,分为载体组、空载体组、对照组。空载体组转染plRES2-EGFP载体,载体组转染plRES2-EGFP-OPG。结果与结论:转染后激光扫描共聚焦显微镜观察可见骨髓基质干细胞内绿色荧光蛋白表达;RT-PCR检测结果可见质粒载体组在1200bp有明显条带,空载体组及对照组未见表达;免疫细胞化学检测骨髓基质干细胞内骨保护素蛋白呈阳性;MTT法检测各组细胞增殖活力无明显改变(P>0.05)。证实应用plRES2-EGFP-骨保护素质粒转染大鼠骨髓基质干细胞,可获得外源性骨保护素的基因及蛋白表达。 BACKGROUND: Genetically modified seed cells for bone tissue engineering can improve the ability to repair bone defects. OBJECTIVE: To detect the expression of osteoprotegerin (OPG) in rat transfected bone marrow stromal cells (BMSCs). METHODS: BMSCs were aseptically obtained from the femur and tibia of 4-week-old SD rats and cultured in vitro. BMSCs were divided into three groups: plasmid group, blank plasmid group and non-transfection group. RESULTS AND CONCLUSION: After transfection, green fluorescent protein was observed in BMSCs under the laser scanning confocal microscope. There was obvious mark at 1 200 bp in plasmid group, but there was no expression of OPG mRNA in blank plasmid group and non-transfection group. The OPG protein was positive in BMSCs detected by immunocytochemistry examination. There were no significant difference in cell proliferation in each group (P 0.05). plRES2- EGFP-OPG plasmid transfected BMSCs can express exogenous OPG and proteins.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第40期7421-7424,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 河北省人事厅留学归国人员科技活动基金资助(200911)~~
  • 相关文献

参考文献1

二级参考文献41

  • 1Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970). The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet, 3(4): 393-403.
  • 2Cancedda R, Mastrogiacomo M, Bianchi G, Derubeis A, Muraglia A, Quarto R (2003). Bone marrow stromal cells and their use in regenerating bone. Novartis Found Syrup, 249: 133-143; discussion 143-147, 170-174, 239-241.
  • 3Derubeis AR, Cancedda R (2004). Bone marrow stromal cells (BMSCs) in bone engineering: limitations and recent advances. Ann Biomed Eng, 32(1): 160-165.
  • 4Owen M, Friedenstein AJ (1988). Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp, 136: 42-60.
  • 5Ng MH, Aminuddin BS, Tan KK, Tan GH, Sabarul Arian M, Ruszymah BH (2004). The use of bone marrow stem cells for bone tissue engineering. MedJ Malaysia, 59(Suppl B): 41-42.
  • 6Minguell JJ, Erices A, Conget P (2001). Mesenchymal stem cells. Exp Biol Med (Maywood), 226(6): 507-520.
  • 7Ringe J, Kaps C, Burmester GR, Sittinger M (2002). Stem cells for regenerative medicine: advances in the engineering of tissues and organs. Naturwissenschaflen, 89(8): 338-351.
  • 8Ringe J, Kaps C, Schmitt B, Buscher K, Bartel J, Smolian H, et al. (2002). Porcine mesenchymal stem cells. Induction of distinct mesenchymal cell lineages. Cell Tissue Res, 307(3): 321-327.
  • 9Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU (1998). In vitro chondrogenesis of bone marrow- derived mesenchymal progenitor cells. Exp Cell Res, 238(1): 265-272.
  • 10Bruder SP, Horowitz MC, Mosca JD, Haynesworth SE (1997). Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone, 21(3): 225-235.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部